ロード中...
Recurrent hepatitis C treatment with direct acting antivirals – a real life study at a Brazilian liver transplant center
Recurrent hepatitis C (HCV) after liver transplantation (LT) is an important cause of morbidity and mortality. Antiviral treatment is recommended to avoid unfavorable outcomes. Direct-acting antivirals (DAA) have transformed HCV treatment, with higher efficacy and fewer side-effects than interferon-...
保存先:
| 出版年: | Braz J Med Biol Res |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Associação Brasileira de Divulgação Científica
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6686270/ https://ncbi.nlm.nih.gov/pubmed/31389490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/1414-431X20198519 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|